Our findings revealed an evidence for the ameliorative impact of BV and DA-nanoparticles against reserpine-evoked PD by restoring monoamines and BDNF levels and eliciting coordinated anti-inflammatory and antioxidant actions. Here, BDNF is linked to Parkinson disease.